Introduction:
Concurrent use of tobacco cigarettes and e-cigarettes ("dual use") is common among tobacco users. Little is known about differences in demographics and toxicant exposure among subsets of dual users.
Aims And Methods:
We analyzed data from adult dual users (current every/some day users of tobacco cigarettes and e-cigarettes, n = 792) included in the PATH Study Wave 1 (2013-2014) and provided urine samples. Samples were analyzed for biomarkers of exposure to nicotine and selected toxicants (tobacco-specific nitrosamine NNK [NNAL], lead, cadmium, naphthalene [2-naphthol], pyrene [1-hydroxypyrene], acrylonitrile [CYMA], acrolein [CEMA], and acrylamide [AAMA]). Subsets of dual users were compared on demographic, behavioral, and biomarker measures to exclusive cigarette smokers (n = 2411) and exclusive e-cigarette users (n = 247).
Results:
Most dual users were predominant cigarette smokers (70%), followed by daily dual users (13%), non-daily concurrent dual users (10%), and predominant vapers (7%). Dual users who smoked daily showed significantly higher biomarker concentrations compared with those who did not smoke daily. Patterns of e-cigarette use had little effect on toxicant exposure. Dual users with high toxicant exposure were generally older, female, and smoked more cigarettes per day. Dual users who had low levels of biomarkers of exposure were generally younger, male, and smoked non-daily.
Conclusions:
In 2013-2014, most dual users smoked cigarettes daily and used e-cigarettes occasionally. Cigarette smoking appears to be the primary driver of toxicant exposure among dual users, with little-to-no effect of e-cigarette use on biomarker levels. Results reinforce the need for dual users to stop smoking tobacco cigarettes to reduce toxicant exposure.
Implications:
With considerable dual use of tobacco cigarettes and e-cigarettes in the United States, it is important to understand differences in toxicant exposure among subsets of dual users, and how these differences align with user demographics. Findings suggest most dual users smoke daily and use e-cigarettes intermittently. Low exposure to toxicants was most common among younger users, males, and intermittent smokers; high exposure to toxicants was most common among older users, females, and heavier cigarette smokers. Results underscore the heterogeneity occurring within dual users, and the need to quit smoking cigarettes completely in order to reduce toxicant exposure.
Citing Articles
Single and multiple tobacco product use among people with disabilities: Findings from the National Health Interview Survey, 2019-2022.
Schulz J, Ganz O, Rubenstein D, West J, Klemperer E
Addict Behav. 2025; 164:108283.
PMID: 39923385
PMC: 11878199.
DOI: 10.1016/j.addbeh.2025.108283.
Biomarkers of Exposure to Nicotine and Selected Toxicants in Individuals Who Use Alternative Tobacco Products Sold in Japan and Canada from 2018 to 2019.
Miller C, Schneller-Najm L, Leigh N, Agar T, Quah A, Cummings K
Cancer Epidemiol Biomarkers Prev. 2024; 34(2):298-307.
PMID: 39636163
PMC: 11799835.
DOI: 10.1158/1055-9965.EPI-24-0836.
The effects of electronic cigarette use patterns on health-related symptom burden and quality of life: analysis of US prospective longitudinal cohort study data.
Cao Y, Zhang X, Fearon I, Li J, Chen X, Xiong Y
Front Public Health. 2024; 12:1433678.
PMID: 39606086
PMC: 11600979.
DOI: 10.3389/fpubh.2024.1433678.
Modeling the Impact of Vaping: What We Need to Know and Which Methods to Use.
Shahab L
Nicotine Tob Res. 2024; 27(3):561-563.
PMID: 39223905
PMC: 11847779.
DOI: 10.1093/ntr/ntae204.
A review of vaping's health effects, treatment, and policy implications: Nursing's call to action.
Buettner-Schmidt K, Fraase K, Barnacle M, Peltier A, Saarinen H, Maack B
Nurse Pract. 2024; 49(9):36-47.
PMID: 39186124
PMC: 11343445.
DOI: 10.1097/01.NPR.0000000000000221.
Sex differences in tobacco use, attempts to quit smoking, and cessation among dual users of cigarettes and e-cigarettes: Longitudinal findings from the US Population Assessment of Tobacco and Health Study.
Klemperer E, Kock L, Feinstein M, Coleman S, Gaalema D, Higgins S
Prev Med. 2024; 185:108024.
PMID: 38849056
PMC: 11269003.
DOI: 10.1016/j.ypmed.2024.108024.
The potential impact of removing a ban on electronic nicotine delivery systems using the Mexico smoking and vaping model (SAVM).
Sanchez-Romero L, Li Y, Zavala-Arciniega L, Gallegos-Carrillo K, Thrasher J, Meza R
medRxiv. 2024; .
PMID: 38746147
PMC: 11092684.
DOI: 10.1101/2024.04.28.24306511.
Cigarette and ENDS dual use longitudinal transitions among adults in the Population Assessment of Tobacco and Health (PATH) Study, Waves 4-5 (2016-2019).
Sharma E, Zebrak K, Lauten K, Gravely S, Cooper M, Gardner L
Addict Behav Rep. 2024; 19:100528.
PMID: 38384864
PMC: 10879705.
DOI: 10.1016/j.abrep.2024.100528.
Response to: Clinical trial shows that giving smokers free e-cigarettes creates more dual users than switchers or quitters.
Carpenter M, Cummings K, Smith T
EClinicalMedicine. 2024; 68:102451.
PMID: 38328753
PMC: 10847052.
DOI: 10.1016/j.eclinm.2024.102451.
Changes in biomarkers of exposure and withdrawal symptom among Chinese adult smokers after completely or partially switching from combustible cigarettes to an electronic nicotine delivery system.
Li C, Guo Y, Duan K, Wang Z, Wu Z, Jiang X
Intern Emerg Med. 2024; 19(3):669-679.
PMID: 38316693
DOI: 10.1007/s11739-023-03518-y.
Comparison of biomarkers of exposure among US adult smokers, users of electronic nicotine delivery systems, dual users and nonusers, 2018-2019.
Holt N, Shiffman S, Black R, Goldenson N, Sembower M, Oldham M
Sci Rep. 2023; 13(1):7297.
PMID: 37147399
PMC: 10163269.
DOI: 10.1038/s41598-023-34427-x.
Biomarkers of Electronic Nicotine Delivery Systems (ENDS) use.
Goniewicz M
Addict Neurosci. 2023; 6.
PMID: 37089248
PMC: 10121191.
DOI: 10.1016/j.addicn.2023.100077.
Associations between biomarkers of nicotine/tobacco exposure and respiratory symptoms among adults who exclusively smoke cigarettes in the U.S.: Findings from the PATH Study Waves 1-4 (2013-2017).
Edwards K, Ozga J, Reyes-Guzman C, Smith D, Hatsukami D, Hart J
Addict Behav Rep. 2023; 17:100487.
PMID: 37008740
PMC: 10060600.
DOI: 10.1016/j.abrep.2023.100487.
The Substitution of Fifty Percent of Combustible Tobacco Smoke Exposure With Either Electronic Cigarettes or Heated tobacco Products Did Not Attenuate Acute Lung Injury in an Animal Model.
Husari A, El-Harakeh M, Shihadeh A, Zeid Daou M, Bitar H, Karaoghlanian N
Nicotine Tob Res. 2023; 25(7):1361-1368.
PMID: 36943313
PMC: 10256882.
DOI: 10.1093/ntr/ntad045.
Understanding heterogeneity among individuals who smoke cigarettes and vape: assessment of biomarkers of exposure and potential harm among subpopulations from the PATH Wave 1 Data.
Lizhnyak P, Noggle B, Wei L, Edmiston J, Becker E, Black R
Harm Reduct J. 2022; 19(1):90.
PMID: 35978343
PMC: 9387076.
DOI: 10.1186/s12954-022-00673-x.
Minor Tobacco Alkaloids as Biomarkers to Distinguish Combusted Tobacco Use From Electronic Nicotine Delivery Systems Use. Two New Analytical Methods.
Jacob P, Chan L, Cheung P, Bello K, Yu L, StHelen G
Front Chem. 2022; 10:749089.
PMID: 35720984
PMC: 9198481.
DOI: 10.3389/fchem.2022.749089.
Changes in Biomarkers of Cigarette Smoke Exposure After 6 Days of Switching Exclusively or Partially to Use of the JUUL System with Two Nicotine Concentrations: A Randomized Controlled Confinement Study in Adult Smokers.
Cohen G, Goldenson N, Bailey P, Chan S, Shiffman S
Nicotine Tob Res. 2021; 23(12):2153-2161.
PMID: 34161586
PMC: 8570669.
DOI: 10.1093/ntr/ntab134.